Cash paid during the period for: Supplemental Cash Flow Information [Abstract] Customer [Domain] Customer [Domain] Gains and Losses on Marketable Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Accounts Receivable, Variable Consideration [Roll Forward] Accounts Receivable, Variable Consideration [Roll Forward] Accounts Receivable, Variable Consideration [Roll Forward] Contingencies Legal Matters and Contingencies [Text Block] Actuarial (gains) losses Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) North America Generics [Member] North America Generics [Member] North America Generics [Member] Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Number of restricted stock awards, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period U.S. State Current Current State and Local Tax Expense (Benefit) Consolidated Entities [Axis] Consolidated Entities [Axis] Taxes related to the net share settlement of equity awards Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net Available-for-sale fixed income securities Debt Securities, Available-for-sale, Current Basic (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Receivable Type [Axis] Receivable Type [Axis] Business Combination, Acquisition Related Costs Business Combination, Acquisition Related Costs Respiratory delivery platform [Member] Respiratory delivery platform [Member] Respiratory delivery platform [Member] Schedule of Property Subject to or Available for Operating Lease Property, Plant, and Equipment, Lessor Asset under Operating Lease [Table Text Block] Cash dividends declared, $0.33 per common share Dividends, Common Stock, Cash Security Exchange Name Security Exchange Name Weighted average grant-date fair value per share, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Payment for Contingent Consideration Liability, Financing Activities Payment for Contingent Consideration Liability, Financing Activities Yupelri ® Yupelri ® [Member] Yupelri ® Number of shares under stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Foreign Currencies Policy Foreign Currency Transactions and Translations Policy [Policy Text Block] Loss Contingency, Patents Allegedly Infringed, Number Loss Contingency, Patents Allegedly Infringed, Number Current liabilities Liability, Defined Benefit Plan, Current Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Investment, Name [Axis] Investment, Name [Axis] Derivatives Policy Derivatives, Policy [Policy Text Block] Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Variable Consideration Category [Domain] Variable Consideration Category [Domain] [Domain] for Variable Consideration Category [Axis] Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Reduction in Share-based Compensation Expense Reduction in Share-based Compensation Expense Reduction in Share-based Compensation Expense Vesting Period [Domain] Vesting Period [Domain] [Domain] for Vesting Period [Axis] Partial payment of anticipated tax expense Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense U.S. State Tax Authority U.S. State Tax Authority [Member] U.S. State Tax Authority [Member] 2022 Long-Term Debt, Maturity, Year Two Intangible assets and goodwill Deferred Tax Liabilities, Intangible Assets Income taxes Increase (Decrease) in Income Taxes Payable Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure 2032 Euro Senior Notes 2032 Euro Senior Notes [Member] 2032 Euro Senior Notes Deferred Bonus Deferred Bonus [Member] 2043 Senior Notes (5.400%) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three Other companies Other Companies [Member] Other companies Fair value hedging relationships Fair Value Hedging [Member] Additions Charged to Costs and Expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Other Comprehensive Income, Other, Net of Tax Other Comprehensive Income, Other, Net of Tax Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Intangible asset amortization expense Intangible asset amortization expense Amortization of Intangible Assets Identified intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Acquired intangible assets, weighted average useful life, in years Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Additions for prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Program Name [Axis] Program Name [Axis] Program Name Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Inventories Schedule of Inventory, Current [Table Text Block] Anti-dilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Upfront payments Payments To Acquire Collaborative Agreement Payments To Acquire Collaborative Agreement Property, plant and equipment Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Business Acquisition [Axis] Business Acquisition [Axis] Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty [Domain] Cash flow hedging relationships Cash Flow Hedging [Mem Cash Flow Hedging [Member] North America Segment North America Segment [Member] North America Segment Three Customers Three Customers [Member] Three Customers Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Award Type [Domain] Award Type [Domain] Local Phone Number Local Phone Number Schedule of Available-for-Sale Securities Reconciliation Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Amortization of actuarial gain/(loss) Defined Benefit Plan, Amortization of Gain (Loss) Number of shares under stock awards, exercisable at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Intangible Assets and Goodwill Policy Goodwill and Intangible Assets, Policy [Policy Text Block] Maturities Of Available-for-Sale Debt Securities At Fair Value Investments Classified by Contractual Maturity Date [Table Text Block] Other Defined Benefit Plan, Other Cost (Credit) Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type [Axis] Damages awarded Loss Contingency, Damages Awarded, Value Deferred Base Salary Deferred Base Salary [Member] Deferred Base Salary [Member] Retained Earnings Retained Earnings [Member] Fair value of long-term debt Debt Instrument, Fair Value Disclosure CHINA CHINA 2020 Euro Senior Notes 2020 Euro Senior Notes [Member] 2020 Euro Senior Notes [Member] Schedule of Other Assets [Table] Schedule of Other Assets [Table] Schedule of Other Assets [Table] Chargebacks [Member] Chargebacks [Member] Chargebacks [Member] Noncontrolling Interest, Ownership Percentage by Parent Noncontrolling Interest, Ownership Percentage by Parent Available-for-sale fixed income investments Debt securities Debt Securities [Member] Earnings (loss) before income taxes and noncontrolling interest: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Upjohn Inc. Upjohn Inc. [Member] Upjohn Inc. [Member] Concentration risk, number of major customers Concentration risk, number of major customers Concentration risk, number of major customers Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Accounting Policies [Line Items] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Measurement Input, Estimated Tax Rate [Member] Measurement Input, Estimated Tax Rate [Member] Measurement Input, Estimated Tax Rate [Member] Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Tax Period [Domain] Tax Period [Domain] Number Of Manufacturing Sites Number Of Manufacturing Sites Number Of Manufacturing Sites 2020 Restructuring Plan 2020 Restructuring Plan [Member] 2020 Restructuring Plan Basic (in USD per share) Basic (loss) earnings per share attributable to Viatris Inc. shareholders Earnings Per Share, Basic Revenue Recognition and Accounts Receivable Revenue from Contract with Customer [Text Block] Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Cash Acquired from Acquisition Cash Acquired from Acquisition Number of restricted stock awards, nonvested beginning balance Number of restricted stock awards, nonvested ending balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Collaborations [Abstract] Collaborations [Abstract] Collaborations [Abstract] 2021 Long-Term Debt, Maturity, Year One Unamortized Debt Issuance Expense Unamortized Debt Issuance Expense Other Current Portion of Long-term Debt Other Current Portion of Long-term Debt [Member] Other Current Portion of Long-term Debt [Member] Current assets (excluding inventories and net of cash acquired) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current SWITZERLAND SWITZERLAND Inventories Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Schedule II - Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Liability, Defined Benefit Pension Plan, Noncurrent Liability, Defined Benefit Pension Plan, Noncurrent Measurement Input, Terminal Year Revenue Growth Rate Measurement Input, Terminal Year Revenue Growth Rate [Member] Measurement Input, Terminal Year Revenue Growth Rate Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Noncurrent assets Assets for Plan Benefits, Defined Benefit Plan Machinery and equipment Machinery and Equipment [Member] Commercial Paper Commercial Paper [Member] Deferred tax liabilities, net Deferred Tax Liabilities, Net Other non-cash items Other Noncash Income (Expense) Fair value of financial instruments Derivative Asset, Fair Value, Gross Asset Business Combination [Abstract] Business Combination [Abstract] Business Combination [Abstract] Plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Net unrecognized gain (loss) on derivatives in hedging relationships Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Period [Domain] Period [Domain] [Domain] for Period [Axis] Other payables Accounts Payable, Other Accounts receivable, net Trade receivables, net Receivables, Net, Current Term Loan Term Loan [Member] Term Loan Transition Service Agreements Transition Service Agreements [Member] Transition Service Agreements Net Third Party Sales Classified Based on Geographic Location of Subsidiaries Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Entity Voluntary Filers Entity Voluntary Filers Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Plan Name [Axis] Plan Name [Axis] Long-term debt Long-term Debt Liabilities, Other than Long-term Debt, Noncurrent Liabilities, Other than Long-term Debt, Noncurrent Level 1 Fair Value, Inputs, Level 1 [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Other liabilities Other Liabilities Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Schedule of Cash, Cash Equivalents, and Restricted Cash Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] [Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table] Entity Small Business Entity Small Business Cash and cash equivalents Cash and Cash Equivalents [Member] Current liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current Impact of foreign currency translation OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax Other Comprehensive Income Defined Benefit Plan Foreign Currency Translation Before Tax Additions for current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations Incremental US Tax on Foreign Earnings Effective Income Tax Rate Reconciliation, GILTI, Percent Effective Income Tax Rate Reconciliation, GILTI, Percent Intangible Assets Excluding Goodwill [Line Items] Finite-Lived Intangible Assets [Line Items] Commitments Commitments Disclosure [Text Block] Scenario [Axis] Scenario [Axis] Common stock issued for the Combination Other Significant Noncash Transaction, Value of Consideration Given Number Of Molecules Number Of Molecules Number Of Molecules Additional paid-in capital Additional Paid in Capital IPR&D intangible asset impairment charges Intangible asset impairment charges Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Unrecognized tax benefits that impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Number of equity method investments Number of equity method investments Number of equity method investments Interest rate swaps Interest rate swap derivatives Interest Rate Swap [Member] Hedging Relationship [Domain] Hedging Relationship [Domain] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] 2026 Senior Notes (3.950%) SeniorNotesTwoThousandTwentySix3.95Precent [Member] 2026 Senior Notes 3.950% Agency mortgage-backed securities Collateralized Mortgage Backed Securities [Member] Entity Interactive Data Current Entity Interactive Data Current Thereafter Long-Term Debt, Maturity, after Year Five 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four Clean energy and research credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Issuance of restricted stock and stock options exercised, net Stock Issued During Period, Value, Stock Options Exercised Recognized net actuarial losses Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Deduction limit of GILTI tax Deduction limit of GILTI tax Deduction limit of GILTI tax Liability for Uncertainty in Income Taxes, Noncurrent Liability for Uncertainty in Income Taxes, Noncurrent Limited transition services period Business Combination, Limited Transition Services Payment Period Business Combination, Limited Transition Services Payment Period Not subject to market conditions Not Subject to Market Conditions [Member] Not Subject to Market Conditions [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Mylan Laboratories Limited Subsidiaries [Member] Unrecognized tax benefit Unrecognized tax benefit — beginning of year Unrecognized tax benefit — end of year Unrecognized Tax Benefits Total deferred tax assets, gross Deferred Tax Assets, Gross Income Tax Authority [Domain] Income Tax Authority [Domain] 2019 Senior Notes (2.550%) SeniorNotesTwoThousandNineteen [Member] Senior notes two thousand nineteen France FRANCE Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Entity Address, State or Province Entity Address, State or Province Restructuring Reserve Restructuring Reserve Senior Notes 2022 Senior Notes 2022 [Member] Senior Notes 2022 Leases Leases of Lessee Disclosure [Text Block] Deferred income tax benefit Deferred Income Tax Assets, Net Issuance of common stock for the Combination Stock Issued During Period, Value, Acquisitions Current liabilities: Liabilities, Current [Abstract] Receivable [Domain] Receivable [Domain] Restructuring Plan [Domain] Restructuring Plan [Domain] GIBRALTAR GIBRALTAR 2018 Senior Revolving Credit Facility [Member] 2018 Senior Revolving Credit Facility [Member] 2018 Senior Revolving Credit Facility [Member] Weighted average exercise price per share, exercisable at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Restructuring Reserve, Settled without Cash Restructuring Reserve, Settled without Cash Total equity securities Equity securities Equity Securities [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Equity consideration Noncash or Part Noncash Divestiture, Amount of Consideration Received 2022 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Average remaining contractual term for options outstanding, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Derivative Instrument [Axis] Derivative Instrument [Axis] Withholding taxes Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Loss Contingency, Patents Found Not Infringed, Number Loss Contingency, Patents Found Not Infringed, Number Vest ratably in five years or less [Member] Vest ratably in five years or less [Member] Vest ratably in five years or less [Member] U.S. Federal Current Current Federal Tax Expense (Benefit) Total lease liability Operating Lease, Liability Balance Sheet Components [Abstract] Balance Sheet Components [Abstract] Balance Sheet Components Document Transition Report Document Transition Report Accumulated other comprehensive income expected to be recognized as net periodic benefit costs Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued and outstanding: 1,209,507,463 and 1,206,895,644, respectively Common Stock, Value, Issued Maximum Leverage Ratio, Period Three Maximum Leverage Ratio, Period Three Maximum Leverage Ratio, Period Three Weighted-average period over which total unrecognized compensation expense expected to be recognized (years) Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Customer Concentration Risk Customer Concentration Risk [Member] Weighted average grant-date fair value per share, nonvested beginning balance Weighted average grant-date fair value per share, nonvested ending balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Lessee, Operating Leases Lessee, Operating Leases [Text Block] Effects of Foreign Exchange Accounts Receivable, Effects of Foreign Exchange Rates Accounts Receivable, Effects of Foreign Exchange Rates Rebates, promotional programs and other sales allowances Accrued Sales Allowances Accrued Sales Allowances Dividends Payable, Amount Per Share Dividends Payable, Amount Per Share Funded status of plans Defined Benefit Plan, Funded (Unfunded) Status of Plan Defined Benefit Plan, Plan Assets, Business Combination Defined Benefit Plan, Plan Assets, Business Combination 2020 Senior Notes (3.750% coupon) Senior Notes Two Thousand Twenty - 3.75 Percent [Member] Senior Notes Two Thousand Twenty - 3.75 Percent Returns Revenue from Contract with Customer, Returns Revenue from Contract with Customer, Returns Acquisitions and Other Transactions Business Combination Disclosure [Text Block] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Auditor [Line Items] Other Commitments [Table] Other Commitments [Table] Stock-Based Compensation Plans, Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] 2027 Senior Notes 2027 Senior Notes [Member] 2027 Senior Notes 2.250% Euro Senior Notes due 2024 2024 Euro Senior Notes [Member] 2024 Euro Senior Notes [Member] Other assets Schedule of Other Assets, Noncurrent [Table Text Block] Ownership [Axis] Ownership [Axis] Non-U.S. Deferred Deferred Foreign Income Tax Expense (Benefit) Aspen Global Incorporated Aspen Global Incorporated [Member] Aspen Global Incorporated Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Goodwill [Line Items] Goodwill [Line Items] Amortization of prior service costs Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Defined benefit plan, ultimate health care cost trend rate Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Marketable Securities Policy Marketable Securities, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Net earnings Business Acquisition, Pro Forma Net Income (Loss) Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Income Tax Authority [Axis] Income Tax Authority [Axis] Work in process Inventory, Work in Process, Net of Reserves MDL Multi District Litigation [Member] Multi District Litigation [Member] Senior Notes 2021 Senior Notes 2021 [Member] Senior Notes 2021 Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock (in shares) Stock Exchanged During Period, Shares, Exchanged Stock Exchanged During Period, Shares, Exchanged Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Common Stock, Dividends, Per Share, Declared Common Stock, Dividends, Per Share, Declared Net sales Net sales Revenue from Contract with Customer, Excluding Assessed Tax Non-contingent payments for product rights Payments for Non-Contingent Consideration for Product Rights, Financing Activities Payments for Non-Contingent Consideration for Product Rights, Financing Activities Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Accrued interest and penalties Income Tax Examination, Penalties and Interest Accrued Finished goods Inventory, Finished Goods, Net of Reserves Corporate costs Corporate costs Corporate costs Consolidated Entity Consolidated Entity, Excluding VIE [Member] Stock options Share-based Payment Arrangement, Option [Member] Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Equity Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] State income taxes and credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Measurement Input Type [Domain] Measurement Input Type [Domain] Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash and Cash Equivalents LUXEMBOURG LUXEMBOURG Rest of World Segment Rest of World Segment [Member] Rest of World Segment Variable Rate [Axis] Variable Rate [Axis] Securitized accounts receivable Accounts Receivable from Securitization Segment Information Segment Reporting Disclosure [Text Block] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] 2.125% Euro Senior Notes due 2025 2024 Euro Senior Notes, 1.023% [Member] 2024 Euro Senior Notes, 1.023% Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Mature in one to five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Trailing Four Quarters Trailing Four Quarters [Member] Trailing Four Quarters Variable Consideration Returns [Member] Variable Consideration Returns [Member] Variable Consideration Returns [Member] Document Fiscal Year Focus Document Fiscal Year Focus Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Variable Rate [Domain] Variable Rate [Domain] Additional Paid-In Capital Additional Paid-in Capital [Member] Intangible assets Deferred Tax Assets Intangible Assets Deferred Tax Assets Intangible Assets Biosimilars Business Biosimilars Business [Member] Biosimilars Business Net unrecognized gains (losses) on derivatives, net of tax, beginning of period Net unrecognized gains (losses) on derivatives, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Repayments of Debt Repayments of Debt Thereafter Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Dividends paid per share Common Stock, Dividends, Per Share, Cash Paid Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Commercial Paper Program [Member] Commercial Paper Program [Member] Commercial Paper Program [Member] Generics Generics [Member] Generics Goodwill, Transfers Goodwill, Transfers Operating lease liabilities Deferred Tax Liabilities, Operating Lease, Liability Deferred Tax Liabilities, Operating Lease, Liability Other assets Other Assets [Member] Waived deductions under IRC § 59A Effective Income Tax Rate Reconciliation, Waived Deductions, Percent Effective Income Tax Rate Reconciliation, Waived Deductions, Percent Other (income) expense, net Other Nonoperating Income (Expense) Other Pension, Postretirement and Supplemental Plans Other Pension, Postretirement and Supplemental Plans [Member] Inventory Recall Expense Inventory Recall Expense Payments for product rights and other, net Payments for (Proceeds from) Other Investing Activities Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Business Combinations [Abstract] Business Combinations [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Rebates, Promotional Programs and Other Sales Allowances [Member] Rebates, Promotional Programs and Other Sales Allowances [Member] Rebates, Promotional Programs and Other Sales Allowances [Member] Maximum Maximum [Member] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] 2028 Euro Senior Notes 2028 Euro Senior Notes [Member] 2028 Euro Senior Notes [Member] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Raw materials Inventory, Raw Materials, Net of Reserves Other current liabilities Schedule of Accrued Liabilities [Table Text Block] Award Type [Axis] Award Type [Axis] Rate used to discount net cash inflows to present values Goodwill Impairment Test, Measurement Input Goodwill Impairment Test, Measurement Input Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of Revenue by Major Customers by Reporting Segments Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Restructuring and Related Cost, Expected Cost Remaining Restructuring and Related Cost, Expected Cost Remaining City Area Code City Area Code Restricted cash, included in other current and non-current assets Restricted cash Restricted Cash and Cash Equivalents, Current Equity Method Investments Equity Method Investments and Joint Ventures Disclosure [Text Block] Designated as hedging instrument Designated as Hedging Instrument [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] IRELAND IRELAND Property, plant and equipment, estimated service life (years) Property, Plant and Equipment, Useful Life India INDIA Viatris Inc. shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Number of states Number of states Number of states Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Concentrations of Credit Risk Policy Concentration Risk, Credit Risk, Policy [Policy Text Block] Operating Lease, Liability, Noncurrent Operating Lease, Liability, Noncurrent Total assets acquired Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Governmental Rebate Programs [Member] Governmental Rebate Programs [Member] Governmental Rebate Programs [Member] Unrecognized net actuarial losses exceed higher of market value of plan assets or the projected benefit obligation at the beginning of the year Accumulated net actuarial losses exceed higher of market value of plan assets or PBO Accumulated net actuarial losses exceed higher of market value of plan assets or PBO Aggregate principal amount Debt Instrument, Face Amount Debt Instrument, Face Amount U.K. Competition and Markets Authority Proceedings Paroxetine U.K. Competition and Markets Authority Proceedings Paroxetine [Member] U.K. Competition and Markets Authority Proceedings Paroxetine Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period Net unrealized gains on marketable securities, net of tax, end of period Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Cardinal Health Inc Cardinal Health Inc [Member] Cardinal Health Inc [Member] Decrease in the aggregate of service and interest cost components of annual expense Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components Interest expense (income) related to uncertain tax positions Income Tax Examination, Interest Expense Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Operating Segments Operating Segments [Member] Finite-Lived Intangible Assets, Period Increase (Decrease) Finite-Lived Intangible Assets, Period Increase (Decrease) Remaining lease terms Lessee, Operating Lease, Term of Contract PUERTO RICO PUERTO RICO Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Restricted Stock Awards Restricted Stock Units (RSUs) [Member] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Additions Charged to Other Accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Anticompetitive Conduct with Generic Drugs Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Fair value of plan assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets Subject to Market Conditions [Domain] Subject to Market Conditions [Domain] [Domain] for Subject to Market Conditions [Axis] Total deferred tax liabilities Deferred Tax Liabilities, Gross Business Acquisition [Line Items] Business Acquisition [Line Items] Other Long Term Debt Other Long Term Debt [Member] Other long term debt. Valuation Technique, Discounted Cash Flow Valuation Technique, Discounted Cash Flow [Member] Investments in subsidiaries Equity Method Investments Income Statement [Abstract] Income Statement [Abstract] Entity Registrant Name Entity Registrant Name Asset Class [Domain] Asset Class [Domain] Diluted (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Weighted average exercise price per share, forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income tax provision (benefit) Income tax related to items of other comprehensive (loss) earnings, derivatives Income Tax Expense (Benefit) Other Commitments [Domain] Other Commitments [Domain] 2021 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Accounts receivable, net Accounts receivable, net Beginning of period End of period Accounts Receivable, after Allowance for Credit Loss, Current Inventory Deferred Tax Assets, Inventory Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Entity Tax Identification Number Entity Tax Identification Number Basic (in shares) Weighted Average Basic Shares Outstanding, Pro Forma Change in Plan Assets Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets Other comprehensive (loss) earnings, before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Assets, Current Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Total lease payments Lessee, Operating Lease, Liability, to be Paid Trade accounts payable Accounts Payable, Trade Accounts Receivable Accounts Receivable [Member] Number of restricted stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Stock appreciation rights and performance shares Stock appreciation rights and performance shares [Member] Stock appreciation rights and performance shares 2016 through 2035 Future years [Member] Future years [Member] Product rights and licenses by therapeutic category Product Rights And Licenses By Therapeutic Category [Table Text Block] Product rights and licenses by therapeutic category Stock-Based Compensation Policy Share-based Payment Arrangement [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Current portion of long-term debt and other long-term obligations Long-term Debt, Current Maturities Loss Contingency, Number of States Loss Contingency, Number of States Loss Contingency, Number of States Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Lyrica ® Lyrica ® [Member] Lyrica ® Restructuring Plan [Axis] Restructuring Plan [Axis] Pfizer, Inc. Pfizer, Inc. [Member] Pfizer, Inc. [Member] Third party net sales Revenue Benchmark [Member] Weighted average grant date fair value per option Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component [Domain] Equity Component [Domain] 2022 Lessee, Operating Lease, Liability, to be Paid, Year One Disposal Group Name [Domain] Disposal Group Name [Domain] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Revance [Member] Revance [Member] Revance [Member] Multiemployer plans, withdrawal obligation Multiemployer Plans, Withdrawal Obligation Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Aspen Pharmacare Holdings Limited Aspen Pharmacare Holdings Limited [Member] Aspen Pharmacare Holdings Limited Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Variable Consideration Category [Axis] Variable Consideration Category [Axis] Variable Consideration Category [Axis] Litigation Case [Axis] Litigation Case [Axis] Derivative Financial Instruments in Cash Flow Hedging Relationships (2) : Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Issuance of common stock for the Combination (in shares) Stock Issued During Period, Shares, Acquisitions Impairment of products rights and licenses intangible assets Impairment of Intangible Assets, Finite-lived Zoloft ® Zoloft ® [Member] Zoloft ® 2040 Senior Notes 2040 Senior Notes [Member] 2040 Senior Notes Restructuring and Related Cost, Incurred Cost Restructuring and Related Cost, Incurred Cost Unrecognized Tax Benefits, Decrease Resulting from Acquisition Unrecognized Tax Benefits, Decrease Resulting from Acquisition Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Liabilities Liabilities [Abstract] Schedule of Allocation of Plan Assets Schedule of Allocation of Plan Assets [Table Text Block] Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Deferred tax liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities Inventory, Firm Purchase Commitment, Loss Inventory, Firm Purchase Commitment, Loss Counterparty Name [Domain] Counterparty Name [Domain] Retirement of Mylan N.V. treasury stock, net Treasury Stock, Retired, Cost Method, Amount Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four 2025 Senior Notes 2025 Senior Notes [Member] 2025 Senior Notes Purchase of marketable securities Payments to Acquire Marketable Securities Measurement Input, Long-term Revenue Growth Rate [Member] Measurement Input, Long-term Revenue Growth Rate [Member] (Loss) earnings before income taxes Operating and non-operating expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Level 2 Fair Value, Inputs, Level 2 [Member] Reduction in Equity Method Investment Long-Term Obligation Reduction in Equity Method Investment Long-Term Obligation Reduction in Equity Method Investment Long-Term Obligation Auditor Location Auditor Location USD Term Loan Facility USD Term Loan Facility [Member] USD Term Loan Facility Amount of loss recognized in earnings on derivatives Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock Stock Exchanged During Period, Value Stock Exchanged During Period, Value Type of Restructuring [Domain] Type of Restructuring [Domain] Segment Reporting [Abstract] Segment Reporting [Abstract] One-Time Special Performance-Based Five-Year Realizable Value Incentive Program One-Time Special Performance-Based Five-Year Realizable Value Incentive Program [Member] One-Time Special Performance-Based Five-Year Realizable Value Incentive Program Subject to Market Conditions Subject to Market Conditions [Member] Subject to Market Conditions Amortized Cost Debt Securities, Available-for-sale, Amortized Cost Finite-lived intangible asset, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life Use of Estimates in the Preparation of Financial Statements Policy Use of Estimates, Policy [Policy Text Block] Earnings Per Common Share Attributable To Mylan Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Antitrust Proceedings Antitrust Proceedings [Member] Antitrust proceedings Title of 12(b) Security Title of 12(b) Security Expected foreign tax credits Deferred Tax Assets, Tax Credit Carryforwards, Foreign Investment, Name [Domain] Investment, Name [Domain] CARES Act, Income Tax Expense (Benefit) CARES Act, Income Tax Expense (Benefit) CARES Act, Income Tax Expense (Benefit) Cash dividends paid Payments to Noncontrolling Interests Ordinary shares, number of shares authorized Common Stock, Shares Authorized Tax settlements and resolution of certain tax positions Effective Income Tax Rate Reconciliation, Tax Settlement, Percent SINGAPORE SINGAPORE Document Type Document Type Trade accounts payable Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Product and Service [Domain] Product and Service [Domain] Fair value loss (gain) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Unrecognized prior service credit (cost) Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Contingent consideration liability Purchase consideration, contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Litigation settlements and other contingencies, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Revolving Credit Facility Revolving Credit Facility [Member] 2023 Senior Notes (4.200%) SeniorNotesTwoThousandTwentyThree4.2Percent [Member] Senior notes two thousand twenty three - 4.2 percent Valuation allowance for deferred tax assets SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Lease, Cost Lease, Cost [Table Text Block] Corporate bonds Corporate Bond Securities [Member] Geographical [Axis] Geographical [Axis] Proceeds from Sale of Securities, Operating Activities Proceeds from Sale of Securities, Operating Activities Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Net sales Product [Member] Net Investment Hedging Net Investment Hedging [Member] Subject to Market Conditions [Axis] Subject to Market Conditions [Axis] Subject to Market Conditions [Axis] Long-term Debt, Weighted Average Interest Rate, at Point in Time Long-term Debt, Weighted Average Interest Rate, at Point in Time Hedging Relationship [Axis] Hedging Relationship [Axis] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Interest Expense [Member] Interest Expense [Member] Mature in five years and later Available for Sale Securities Debt Maturities after Five Years and Later Fair Value Available for sale securities debt maturities after five years and later fair value. Amortization of prior service costs included in SG&A Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities 2019 Senior Notes (2.500%) SeniorNotesTwoThousandNineteen2.50Precent [Member] 2019 Senior Notes (2.500%) Contingent consideration Contingent Consideration [Member] Contingent Consideration. Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Stock option award vesting period, in years Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Variable Consideration [Member] Variable Consideration [Member] Variable Consideration [Member] 2030 Senior Notes 2030 Senior Notes [Member] 2030 Senior Notes Loss from equity method investments Income (Loss) from Equity Method Investments Equity securities — exchange traded funds Exchange Traded Funds [Member] Nonvested Restricted Stock and Restricted Stock Unit, Including Performance Units, Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Period [Axis] Period [Axis] Period [Axis] Restructuring and Related Cost, Cost Incurred to Date Restructuring Charges Concentration Risk Type [Axis] Concentration Risk Type [Axis] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Foreign Foreign Tax Authority Foreign Tax Authority [Member] Estimated Litigation Liability, Current Estimated Litigation Liability, Current Accounts Payable, Current [Abstract] Accounts Payable, Current [Abstract] Contingent Consideration Policy Business Combinations Policy [Policy Text Block] Derivative [Table] Derivative [Table] Cancellation of restricted stock Treasury Stock, Shares, Retired Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Revenues: Revenues [Abstract] Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Document Period End Date Document Period End Date Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Projected benefit obligation Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation Proceeds from Sale and Collection of Receivables Proceeds from Sale and Collection of Receivables Fixed income securities Fixed Income Securities [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Consolidated Entities [Domain] Consolidated Entities [Domain] Insulin Analog Products Insulin Analog Products Insulin Analog Products Total Expected Future Benefit Payments Expected Future Benefit Payments Complex Gx and Biosimilars Complex GX and Biosimilars [Member] Complex GX and Biosimilars U.S. State Deferred Deferred State and Local Income Tax Expense (Benefit) Emerging Markets Emerging Markets Segment [Member] Emerging Markets Segment Property, plant and equipment Property, Plant and Equipment [Table Text Block] Greater China Greater China Segment [Member] Greater China Segment Receivables Facility [Member] Receivables Facility [Member] Receivables facility. Debt Instrument, Term Debt Instrument, Term Income Statement Location [Domain] Income Statement Location [Domain] Medicaid and other governmental rebates Medicaid and other governmental rebates Medicaid and other governmental rebates Derivative Asset (Liability) Net, Measurement Input Derivative Asset (Liability) Net, Measurement Input Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Total operating expenses Operating Expenses Land and improvements Land and Land Improvements [Member] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Payments of long-term debt Repayments of Long-term Debt Goodwill, Impaired, Change in Estimate, Period Goodwill, Impaired, Change in Estimate, Period Goodwill, Impaired, Change in Estimate, Period (Loss) earnings per share attributable to Viatris Inc. shareholders Earnings Per Share [Abstract] Earnings Per Share [Abstract] Collaborative Arrangement Collaborative Arrangement [Member] Property, plant and equipment, gross Property, Plant and Equipment, Gross Rate used to discount net cash inflows to present values Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input Total revenues Total revenues Revenues Income tax provision (benefit), Non-U.S. Foreign Income Tax Expense (Benefit), Continuing Operations Contingent consideration Other Liabilities, Fair Value Disclosure Foreign Exchange Contract Foreign currency borrowings and forward contracts Foreign Exchange Contract [Member] Loss contingency accrual Loss Contingency Accrual 2022 Euro Senior Notes 2022 Euro Senior Notes [Member] 2022 Euro Senior Notes Fiscal Year 2017 Fiscal Year 2017 [Member] Fiscal Year 2017 [Member] Other Commitments [Line Items] Other Commitments [Line Items] Weightedaverage exercise price per share, outstanding at beginning of period Weighted average exercise price per share, outstanding at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Deferred income tax benefit Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Asset Acquisition [Domain] Asset Acquisition [Domain] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Entity Current Reporting Status Entity Current Reporting Status Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Fair value of plan assets, beginning of year Fair value of plan assets, end of year Fair value of plan assets Defined Benefit Plan, Plan Assets, Amount Effective tax rate Effective Income Tax Rate Reconciliation, Percent Net accrued benefit costs Net accrued benefit costs Net accrued benefit costs Other Other Debt Obligations [Member] Debt, Current Debt, Current Counterparty Name [Axis] Counterparty Name [Axis] Proceeds from the sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Dymista ® Dymista ® [Member] Dymista ® Shares issued Balance (in shares) Balance (in shares) Shares, Issued Amounts accrued Business Combination, Contractual Reimbursement Amount, Amounts Accrued Business Combination, Contractual Reimbursement Amount, Amounts Accrued United States UNITED STATES Measurement Input, Discount Rate [Member] Measurement Input, Discount Rate [Member] Amounts incurred Business Combination, Contractual Reimbursement Amount, Amounts Expensed Business Combination, Contractual Reimbursement Amount, Amounts Expensed Restructuring Reserve, Reimbursable Restructuring Charges Restructuring Reserve, Reimbursable Restructuring Charges Restructuring Reserve, Reimbursable Restructuring Charges Common stock shares reserved for issuance to employees Common Stock, Capital Shares Reserved for Future Issuance Leases [Abstract] Leases [Abstract] Income Taxes Policy Income Tax, Policy [Policy Text Block] London Interbank Offered Rate (LIBOR) [Member] London Interbank Offered Rate (LIBOR) [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Schedule of Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Revenue Recognition Policy Revenue from Contract with Customer [Policy Text Block] Diluted (in shares) Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Earnings before income taxes and noncontrolling interest, United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Total intangible asset amortization expense (including impairment charges) Amortization Income Taxes Income Tax Disclosure [Text Block] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Stock Awards Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Debt Instrument, Basis Spread on Variable Rate Debt Instrument, Basis Spread on Variable Rate Insulin Glargine Insulin Glargine [Member] Insulin Glargine Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] 2018 Senior Notes (2.600%) Senior Notes Two Thousand Eighteen - 2.6 Percent [Member] Senior Notes Two Thousand Eighteen - 2.6% [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input 2020 Floating Rate Euro Notes 2020 Floating Rate Euro Notes [Member] 2020 Floating Rate Euro Notes Not designated as hedging instrument Not Designated as Hedging Instrument [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Restructuring Reserve, Noncurrent Restructuring Reserve, Noncurrent Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Principles of Consolidation Policy Consolidation, Policy [Policy Text Block] Entity Shell Company Entity Shell Company Schedule of Short-term Debt Schedule of Short-term Debt [Table Text Block] Net assets Equity Method Investment Summarized Financial Information, Net Assets Equity Method Investment Summarized Financial Information, Net Assets Expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Current liabilities Liabilities, Current Taxes paid related to net share settlement of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Supply Commitment [Axis] Supply Commitment [Axis] Foreign Exchange Forward Foreign Exchange Forward [Member] EURIBOR [Member] EURIBOR [Member] EURIBOR [Member] Money market funds Money Market Funds [Member] Accounts payable Accounts payable Accounts Payable, Trade, Current Loss Contingencies [Table] Loss Contingencies [Table] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Plans with Accumulated Benefit Obligation in Excess of Plan Assets Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Financial Instruments And Risk Management Financial Instruments Disclosure [Text Block] Loss Contingency, Damages Awarded On Appeal, Value Loss Contingency, Damages Awarded On Appeal, Value Loss Contingency, Damages Awarded On Appeal, Value Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Long Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Statement [Table] Accounting Policies [Table] Statement [Table] Business Acquisition, expected future payments, next twelve months Business Acquisition, expected future payments, next twelve months Business Acquisition, expected future payments, next twelve months Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Other Deferred Tax Assets, Other Other Commitments [Axis] Other Commitments [Axis] 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Goodwill [Member] Goodwill [Member] Total unrecognized compensation expense, net of estimated forfeitures Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Range [Axis] Statistical Measurement [Axis] Accounts receivable, net Accounts Receivable [Policy Text Block] Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Subsequent Event Subsequent Event [Member] Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax Finite-lived intangible assets, net Finite-lived intangible assets, net book value Finite-Lived Intangible Assets, Net Goodwill Goodwill, net, ending balance Goodwill Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Measurement Input, Increase in Discount Rate Measurement Input, Increase in Discount Rate [Member] Measurement Input, Increase in Discount Rate U.S. rate differentials Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Changes in carrying amount of goodwill Schedule of Goodwill [Table Text Block] Scenario, Unspecified [Domain] Scenario [Domain] Three Full Fiscal Quarters Following Qualifying Acquisition Three Full Fiscal Quarters Following Qualifying Acquisition [Member] Three Full Fiscal Quarters Following Qualifying Acquisition [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Defined Pension Plan Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Defined contribution plan, maximum annual contribution per employee, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Deferred income tax expense (benefit) Deferred Income Tax Expense (Benefit) Average remaining contractual term for options vested and expected to vest, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Xalabrands Xalabrands [Member] Xalabrands Australian Taxation Office Australian Taxation Office [Member] Deferred income tax benefit Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Hedging Designation [Domain] Hedging Designation [Domain] Stock Repurchase Program, Authorized Amount Stock Repurchase Program, Authorized Amount Asset Acquisition [Axis] Asset Acquisition [Axis] Other noncurrent liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Number of drugs Number of drugs Number of drugs Statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Earnings Per Common Share Policy Earnings Per Share, Policy [Policy Text Block] Restructuring Reserve, Acquired During Period Restructuring Reserve, Acquired During Period Restructuring Reserve, Acquired During Period TOBI TOBI [Member] TOBI [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Operating Lease, Right-of-Use Asset Right-of-use asset Operating Lease, Right-of-Use Asset Interest cost Defined Benefit Plan, Interest Cost Employee-related Liabilities, Current Employee-related Liabilities, Current Receivables, Net, Current [Abstract] Receivables, Net, Current [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Range [Domain] Statistical Measurement [Domain] EU Commission Proceedings Perindorpril EU Commission Proceedings Perindorpril [Member] EU Commission Proceedings Perindorpril Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member] 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan Senior Notes 2023 3.125% SeniorNotesTwoThousandTwentyThree3.125Percent [Member] Senior notes two thousand twenty three - 3.125 percent Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Restructuring Type [Axis] Restructuring Type [Axis] Other assets Other assets Other Assets, Noncurrent Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Defined benefit plan, ultimate health care cost trend rate, projected Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Segments [Axis] Segments [Axis] Retirement Benefits [Abstract] Retirement Benefits [Abstract] In-process research and development In Process Research and Development [Member] Entity File Number Entity File Number 2021 Senior Notes (3.150%) SeniorNotesTwoThousandTwentyOne3.15Precent [Member] 2021 Senior Notes 3.15% Share-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Viagra ® Viagra ® [Member] Viagra ® Effect on Future Cash Flows, Amount Effect on Future Cash Flows, Amount Credit Concentration Risk Credit Concentration Risk [Member] Accumulated benefit obligation Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Vesting Period [Axis] Vesting Period [Axis] Vesting Period [Axis] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Payments of financing fees Payments of Financing Costs Employee benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Clean energy investments Clean Energy Partnerships [Member] Clean Energy Partnerships Liability Class [Axis] Liability Class [Axis] Building Building [Member] Twenty Twenty One Loan Facilities Twenty Twenty One Loan Facilities [Member] Twenty Twenty One Loan Facilities EpiPen® Auto-Injectors EpiPen® Auto-Injectors [Member] EpiPen® Auto-Injectors Equity Method Investment, Other than Temporary Impairment Equity Method Investment, Other than Temporary Impairment Accretion expense expected within 12 months Accretion Expense to be Recognized within the Next Twelve Months Accretion Expense to be Recognized within the Next Twelve Months Weighted average grant-date fair value per share, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Impact of foreign currency translation Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets Disposal Group Name [Axis] Disposal Group Name [Axis] Noncurrent liabilities Liability, Defined Benefit Plan, Noncurrent Derivative Financial Instruments Not Designated as Hedging Instruments: Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Assets Assets [Abstract] Reimbursement amount, tranche one Business Combination, Contractual Reimbursement Amount, Tranche One Business Combination, Contractual Reimbursement Amount, Tranche One Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill 2023 Long-Term Debt, Maturity, Year Three Goodwill, Impaired, Accumulated Impairment Loss Accumulated impairment losses, beginning balance Accumulated impairment losses, ending balance Goodwill, Impaired, Accumulated Impairment Loss Weighted average exercise price per share, vested and expected to vest at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Debt Instrument, Covenant Description Debt Instrument, Covenant Description Segment Reconciling Segment Reconciling Items [Member] Number of restricted stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Maximum Leverage Ratio, Period One Maximum Leverage Ratio, Period One Maximum Leverage Ratio, Period One Anticompetitive conduct with respect to additional generic drugs Anticompetitive conduct with respect to additional generic drugs [Member] Anticompetitive conduct with respect to additional generic drugs Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Concentration risk, percentage Concentration Risk, Percentage Property, Plant and Equipment Policy Property, Plant and Equipment, Policy [Policy Text Block] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain] Impairment of Equity Method Investments Impairment of Equity Method Investments Impairment of Equity Method Investments Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of shares under stock awards, outstanding at beginning of period Number of shares under stock awards, outstanding at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Debt Instrument [Axis] Debt Instrument [Axis] Term of operating leases not yet commenced Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Increase in the benefit obligation Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation Participant contributions DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation Defined Benefit Plan Contributions By Plan Participants Benefit Obligation Series of Individually Immaterial Business Acquisitions Series of Individually Immaterial Business Acquisitions [Member] Accounts receivable securitization facility maximum borrowing capacity Accounts Receivable Facility Maximum Borrowing Capacity Accounts receivable facility maximum borrowing capacity. Increased Discount Rate [Domain] Increased Discount Rate [Domain] Increased Discount Rate [Domain] Rate used to discount net cash inflows to present values Business Combination, Contingent Consideration, Liability, Measurement Input Finite-Lived Intangible Assets Finite-Lived Intangible Assets [Member] Net assets acquired (net of $415.8 of cash acquired) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Interest expense Deferred Tax Assets, Deferred tax expense, interest expense Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from interest expense. Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Unrecognized actuarial (gain) loss Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other noncurrent liabilities Other Noncurrent Liabilities [Table Text Block] Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block] Equity securities Equity Securities, FV-NI Tax settlements and resolution of certain tax positions Effective Income Tax Rate Reconciliation, India Amagulation Effective Income Tax Rate Reconciliation, India Amagulation Other comprehensive (loss) earnings, before tax Other comprehensive (loss) earnings, before tax Other Comprehensive Income (Loss), before Tax Indefinite Indefinite [Member] Indefinite amount of time Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Loss Contingency, Remaining Claims, Number Loss Contingency, Remaining Claims, Number Loss Contingency, Remaining Claims, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three 2014 Program 2014 Program [Member] 2014 Program Allowance for doubtful accounts SEC Schedule, 12-09, Allowance, Credit Loss [Member] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Expected Long-term Return on Assets Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Expected Long-term Return on Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Prepaid expenses Prepaid Expense, Current Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] 2025 Long-Term Debt, Maturity, Year Five Total employer contributions Defined Contribution Plan, Cost Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Tax credit and loss carry-forwards Deferred Tax Assets, Tax Credit Carryforwards Amount of common stock shares authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Change in short-term borrowings, net Proceeds from (Repayments of) Short-term Debt Number of cases Number of cases Number of cases JANZ Japan, Australia and New Zealand Segment [Member] Japan, Australia and New Zealand Segment Research and Development Policy Research and Development Expense, Policy [Policy Text Block] Theravance Theravance Biopharma [Member] Theravance Biopharma Acquisition purchase price Business Combination, Consideration Transferred Income tax provision (benefit), U.S. Federal Federal Income Tax Expense (Benefit), Continuing Operations Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member] Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member] Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member] Long-term Debt, Gross Total Long-term Debt, Gross Other noncurrent liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Liabilities Total assets at recurring fair value measurement Assets, Fair Value Disclosure 2020 Revolving Facility 2020 Revolving Facility [Member] 2020 Revolving Facility Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Total liabilities and equity Liabilities and Equity Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Other Accrued Liabilities, Current Other Accrued Liabilities, Current AmeriSourceBergen Corporation AmeriSourceBergen Corporation [Member] AmeriSourceBergen Corporation Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 2026 Lessee, Operating Lease, Liability, to be Paid, Year Five Net unrealized (loss) gain on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax Weighted average exercise price per share, exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Restricted Cash Restricted Cash Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Supplemental disclosures of cash flow information — Supplemental Cash Flow Elements [Abstract] Generic Biologic Compounds Collaboration [Member] Generic Biologic Compounds Collaboration [Member] Generic Biologic Compounds Collaboration 2022 Senior Notes 2022 Senior Notes [Member] 2022 Senior Notes 2025 Euro Senior Notes 2025 Euro Senior Notes [Member] 2025 Euro Senior Notes [Member] Derivative [Line Items] Derivative [Line Items] Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Current Provision Related to Sales Made in the Current Period Accounts Receivable, Sales Provisions, Current Accounts Receivable, Sales Provisions, Current Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Income Tax Contingency [Table] Income Tax Contingency [Table] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Increase in the aggregate of service and interest cost components of annual expense Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components Operating expenses: Operating Expenses [Abstract] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Prepaid Expense and Other Assets, Current [Abstract] Prepaid Expense and Other Assets, Current [Abstract] 2020 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Minimum Minimum [Member] Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Restructuring Reserve, Period Increase (Decrease) Restructuring Reserve, Period Increase (Decrease) Note Securitization Facility [Member] Note Securitization Facility [Member] Note Securitization Facility [Member] Gross profit Gross loss Gross Profit 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Total liabilities at recurring fair value measurement Financial and Nonfinancial Liabilities, Fair Value Disclosure Selling, general and administrative Selling, General and Administrative Expense Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Net realizable value of inventory recognized as expense Net realizable value of inventory recognized as expense Net realizable value of inventory recognized as expense April 2018 Senior Notes [Member] April 2018 Senior Notes [Member] April 2018 Senior Notes [Member] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Other Assets, Noncurrent [Abstract] Other Assets, Noncurrent [Abstract] Influvac ® Influvac ® [Member] Influvac ® Restructuring Reserve, Translation and Other Adjustment Restructuring Reserve, Translation and Other Adjustment Other comprehensive earnings (loss) before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax U.S. Federal Tax Authority U.S. Federal Tax Authority [Member] U.S. Federal Tax Authority [Member] Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired 2024 Long-Term Debt, Maturity, Year Four Stock Issued During Period, Value, New Issues Stock Issued During Period, Value, New Issues Future unrecognized actuarial losses Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year Measurement Period Adjustments and Reclasses Accounts Receivable, Increase Due to Acquisition, Current Accounts Receivable, Increase Due to Acquisition, Current Cash received (paid) for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Debt Debt Disclosure [Text Block] Other Restructuring Other Restructuring [Member] Schedule of Components of Income Tax Provision Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Line of Credit Line of Credit [Member] Scenario, Plan Scenario, Plan [Member] Share-Based Incentive Plan Share-based Payment Arrangement [Text Block] Senior Notes Senior Notes [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Divestiture of Business, Deferred Cash Consideration. Divestiture of Business, Deferred Cash Consideration. Divestiture of Business, Deferred Cash Consideration. Tax Year 2015 Tax Year 2015 [Member] Net unrealized gain on marketable securities, net of tax Net unrealized gains on marketable securities, net of tax, beginning of period Net unrealized gains on marketable securities, net of tax, end of period AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax Issuance of common stock to Mylan N.V. shareholders (in shares) Stock Issued During Period, Shares, New Issues Schedule of other current liabilities [Line Items] Schedule of other current liabilities [Line Items] [Line Items] for Schedule of other current liabilities [Table] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Inventory, Net [Abstract] Inventory, Net [Abstract] Acquisitions Goodwill, Acquired During Period Other Postretirement Benefits Other Postretirement Benefits Plan [Member] Performance Shares Performance Shares [Member] Noncurrent assets Assets, Noncurrent Contractual Rights Contractual Rights [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss, net of tax, beginning of period Accumulated other comprehensive loss, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company Supply Commitment Arrangement [Domain] Supply Commitment Arrangement [Domain] Medium-term Notes Medium-term Notes [Member] Impact of foreign currency translation Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Restricted stock Restricted Stock [Member] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt Auditor Name Auditor Name Cover [Abstract] Cover [Abstract] Diluted (in shares) Pro Forma Weighted Average Shares Outstanding, Diluted Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Derivative Financial Instruments in Net Investment Hedging Relationships: Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Cash and Cash Equivalents Policy Cash and Cash Equivalents, Policy [Policy Text Block] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block] Fair value loss (gain) Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Financial Instrument [Axis] Short-term Debt [Line Items] Short-term Debt [Line Items] Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Schedule of Other Assets [Line Items] Schedule of Other Assets [Line Items] [Line Items] for Schedule of Other Assets [Table] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Other revenues Revenue Not from Contract with Customer Payments for Restructuring Payments for Restructuring Other Foreign Operations Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent Common Stock Marketable securities Common Stock [Member] Sales Milestone Payments Sales Milestone Payments Sales Milestone Payments Earnings before income taxes and noncontrolling interest, foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign (Loss) earnings from operations Segment profitability Operating Income (Loss) 2018 Senior Notes (3.000% coupon) Senior Notes Two Thousand Eighteen - 3.0 Percent [Member] Senior Notes Two Thousand Eighteen - 3.0 Percent Amount of Gain Excluded from the Assessment of Hedge Effectiveness Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Operating Lease, Liability, Current Operating Lease, Liability, Current Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Collaborative and Licensing Agreements Collaborative Arrangement Disclosure [Text Block] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Measurement Input, Reduction in Terminal Year Revenue Growth Rate Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member] Measurement Input, Reduction in Terminal Year Revenue Growth Rate Hedging Designation [Axis] Hedging Designation [Axis] Foreign currency translation adjustment Foreign currency translation adjustment, beginning of period Foreign currency translation adjustment, end of period Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Share-based compensation expense Share-based Payment Arrangement, Noncash Expense Restructuring and Related Activities Disclosure [Text Block] Restructuring and Related Activities Disclosure [Text Block] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Depreciation Depreciation Other foreign Other foreign [Member] Other foreign [Member] 2046 Senior Notes (5.250%) SeniorNotesTwoThousandFortySix5.25Precent [Member] 2046 Senior Note (5.250%) Treasury Stock Treasury Stock [Member] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Dimethyl Fumarate Dimethyl Fumarate [Member] Dimethyl Fumarate Income taxes Income Taxes Paid McKesson Corporation McKesson Corporation [Member] McKesson Corporation [Member] Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Income Tax Examination, Reserve Impact On Income Tax Provision Income Tax Examination, Reserve Impact On Income Tax Provision Income Tax Examination, Reserve Impact On Income Tax Provision Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Plan curtailment, settlement and termination Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment Unregistered Upjohn U.S. Dollar Notes Unregistered Upjohn U.S. Dollar Notes [Member] Unregistered Upjohn U.S. Dollar Notes Capital expenditures Payments to Acquire Property, Plant, and Equipment Other current liabilities Other Liabilities, Current Other Liabilities, Current Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Company contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Business Combinations, Number of Agreements Business Combinations, Number of Agreements Business Combinations, Number of Agreements Operating leases expense Operating Leases, Rent Expense, Net Total liabilities Total liabilities Liabilities Deferred tax assets: Deferred Tax Assets, Net [Abstract] 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Weighted average exercise price per share, granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Aggregate intrinsic value for options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Goodwill Impairment Test, Measurement Input, Increase Goodwill Impairment Test, Measurement Input, Increase Goodwill Impairment Test, Measurement Input, Increase Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Measurement Input Type [Axis] Measurement Input Type [Axis] Consolidation Items [Axis] Consolidation Items [Axis] Creon ® Creon ® [Member] Creon ® Net operating loss carryforwards Operating Loss Carryforwards Total Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax Change in unrecognized loss and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Net change Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Schedule of Assumptions Used Defined Benefit Plan, Assumptions [Table Text Block] Entity Address, City or Town Entity Address, City or Town Schedule of Expected Benefit Payments Schedule of Expected Benefit Payments [Table Text Block] Current portion of long-term debt Current Portion of Long-Term Debt [Member] Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Non-cash transactions: Noncash Investing and Financing Items [Abstract] North America Specialty [Member] North America Specialty [Member] North America Specialty [Member] Capitalized software Software and Software Development Costs [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] 2050 Senior Notes 2050 Senior Notes [Member] 2050 Senior Notes Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Interest expense Interest expense Interest Expense Product rights and licenses Licensing Agreements [Member] Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets (Reduction) addition due to acquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition Debt instrument, interest rate at period end Debt Instrument, Interest Rate, Effective Percentage Other assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Business Acquisition, expected future payment, year two Business Acquisition, expected future payment, year two 2019 Defined Benefit Plan, Expected Future Benefit Payment, Year One Retained earnings Retained Earnings (Accumulated Deficit) Amount of unrecognized deferred tax liability Increase in Unrecognized Tax Benefits is Reasonably Possible Litigation Case [Domain] Litigation Case [Domain] Stock option award expiration period, in years Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Contingent consideration payments Payments of Merger Related Costs, Financing Activities Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Equity Method Investments Equity Method Investments [Table Text Block] Entity Filer Category Entity Filer Category Developed Markets Developed Markets Segment [Member] Developed Markets Segment Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Effect of Derivative Instruments on the Consolidated Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] U.S. Treasuries US Treasury Securities [Member] Celebrex ® Celebrex ® [Member] Celebrex ® 2028 Senior Notes 2028 Senior Notes [Member] 2028 Senior Notes [Member] [Member] Accretion Accretion Expense In-process research and development Indefinite-lived Intangible Assets (Excluding Goodwill) Capitalized Computer Software, Net Capitalized Computer Software, Net Proceeds from exercise of stock options Proceeds from Stock Options Exercised Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Total equity Balance Balance Total equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Amendment Flag Amendment Flag Proceeds from issuance of long-term debt Proceeds from Issuance of Long-term Debt Equity Components [Axis] Equity Components [Axis] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Gains and Losses on Derivatives in Cash Flow Hedging Relationships Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Inventories Inventories Inventory, Net Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Number of shares under stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures U.S. Federal Deferred Deferred Federal Income Tax Expense (Benefit) Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five EU Commission Proceedings Citalopram EU Commission Proceedings Citalopram [Member] EU Commission Proceedings Citalopram Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Deferred tax liability not recognized, amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Product and Service [Axis] Product and Service [Axis] Entity Public Float Entity Public Float Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Transferred assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan Jai Pharma Limited Jai Pharma Limited [Member] Jai Pharma Limited Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract] Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 2016 Term Loans 2016 Term Loans [Member] 2016 Term Loans [Member] Statement [Line Items] Statement [Line Items] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Divestiture Of Business, Transition Services Agreement, Term Divestiture Of Business, Transition Services Agreement, Term Divestiture Of Business, Transition Services Agreement, Term Current assets (excluding inventories and net of cash acquired) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Amount awarded to other party Litigation Settlement, Amount Awarded to Other Party Loss Contingency, Other Asserted Patents, Number Loss Contingency, Other Asserted Patents, Number Loss Contingency, Other Asserted Patents, Number Retirement Plan Type [Domain] Retirement Plan Type [Domain] Domestic Tax Authority Domestic Tax Authority [Member] Fair Value Available-for-sale securities, debt securities Debt Securities, Available-for-sale YEN Term Loan YEN Term Loan [Member] YEN Term Loan Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage Debt Disclosure [Abstract] Debt Disclosure [Abstract] Chargebacks Chargebacks Chargebacks Tax Period [Axis] Tax Period [Axis] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Valuation allowance, amount Less: Valuation allowance Deferred Tax Assets, Valuation Allowance Corporate (Other) Corporate, Non-Segment [Member] Marketable Securities Marketable Securities [Member] Marketable Securities Number Of Markets Business Combination, Number Of Markets Served Business Combination, Number Of Markets Served Decrease in the benefit obligation Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation Other expense Other income Other Expense [Member] Customer [Axis] Customer [Axis] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Employee Benefits Retirement Benefits [Text Block] Trade accounts payable Increase (Decrease) in Accounts Payable, Trade Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Twenty Twenty One Revolving Facility Twenty Twenty One Revolving Facility [Member] Twenty Twenty One Revolving Facility Asset Class [Axis] Asset Class [Axis] Document Annual Report Document Annual Report Scenario, Forecast Forecast [Member] Income tax provision (benefit), U.S. State State and Local Income Tax Expense (Benefit), Continuing Operations Program Name [Domain] Program Name [Domain] [Domain] for Program Name Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Income tax provision (benefit) Other Comprehensive Income (Loss), Tax Total assets Total assets Assets Litigation settlements and other contingencies, net Litigation settlements & other contingencies Gain (Loss) Related to Litigation Settlement EpiPen Auto-Injector Litigation EpiPen Auto-Injector Litigation [Member] EpiPen Auto-Injector Litigation Plan Name [Domain] Plan Name [Domain] Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Mylan N.V. Mylan Parent Company [Member] Research and development Globally managed research and development costs Research and Development Expense Schedule of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Unrecognized prior service cost (credit) Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax Derivative Contract Type [Domain] Derivative Contract [Domain] FKB FKB [Member] FKB [Member] Acquisitions Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan Other long-term assets Other long-term assets Other long-term assets Noncurrent liabilities Liabilities, Noncurrent Summary Of Significant Accounting Policies Significant Accounting Policies [Text Block] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Short-term borrowings Short-term borrowings Short-term Debt Credit carryforward Tax Credit Carryforward, Amount Revenue Recognition And Accounts Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Summary of Long-Term Debt Schedule of Debt [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Other receivables Other Receivables, Net, Current Agila Specialties Agila Specialties Private Limited [Member] Agila Specialties Private Limited Impact of the Combination and Divestitures Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Basic (in shares) Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Diluted (in USD per share) Diluted (loss) earnings per share attributable to Viatris Inc. shareholders Earnings Per Share, Diluted Segments [Domain] Segments [Domain] Service cost Defined Benefit Plan, Service Cost Loss contingency accrual Loss Contingency, Damages Paid, Value Unrecognized actuarial (gain) loss Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Xanax ® Xanax ® [Member] Xanax ® Sales [Member] Sales [Member] Other Foreign Operations Non-US [Member] Business Acquisition, Date of Acquisition [Abstract] Business Acquisition, Date of Acquisition [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Finite-lived Intangible Assets Amortization Expense [Table Text Block] Finite-lived Intangible Assets Amortization Expense [Table Text Block] Intangible assets, net Intangible assets, net book value, excluding goodwill Intangible Assets, Net (Excluding Goodwill) Employee Severance Employee Severance [Member] Restructuring Reserve, Current Restructuring Reserve, Current Restructuring and Related Cost, Expected Number of Positions Eliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Net Accrued Benefit Costs Classification on Balance Sheet Schedule of Amounts Recognized in Balance Sheet [Table Text Block] Short-Term Borrowings Debt, Policy [Policy Text Block] Deferred income tax liability Deferred Income Tax Liabilities, Net Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Statutory Tax Rate to Effective Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] 2027 Euro Senior Notes 2027 Euro Senior Notes [Member] 2027 Euro Senior Notes Accounts receivable allowances Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss Depreciation and amortization Depreciation, Depletion and Amortization Measurement Input, Control Premium [Member] Measurement Input, Control Premium [Member] Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Impact of changes in legislation Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year Inventories Increase (Decrease) in Inventories Schedule of Other Noncurrent Liabilities [Line Items] Schedule of Other Noncurrent Liabilities [Line Items] [Line Items] for Schedule of Other Noncurrent Liabilities [Table] Convertible Preferred Stock Convertible Preferred Stock [Member] Restructuring and Related Costs [Table Text Block] Restructuring and Related Costs [Table Text Block] Financial Instruments [Domain] Financial Instruments [Domain] Cost of sales Cost of Goods and Services Sold Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] [Line Items] for Schedule of Product Rights and Licenses by Therapeutic Class Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Proceeds from sale of assets and subsidiaries Proceeds from Divestiture of Businesses Entity Central Index Key Entity Central Index Key Other revenues Product and Service, Other [Member] Reduction in Terminal Value Growth Rate [Domain] Reduction in Terminal Value Growth Rate [Domain] Reduction in Terminal Value Growth Rate [Domain] Amitiza ® Amitiza ® [Member] Amitiza ® Plan settlements and terminations Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Reductions for prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Loss Contingencies [Line Items] Loss Contingencies [Line Items] Foreign deductible attributes Deferred Tax Assets, Tax Deferred Expense Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Long-term debt, including current portion Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Other long-term obligations Other Liabilities, Noncurrent Other Liabilities, Noncurrent Assets held by insurance companies and other Assets held by insurance companies and other [Member] Assets held by insurance companies and other [Member] Projected benefit obligation, beginning of year Projected benefit obligation, end of year Defined Benefit Plan, Benefit Obligation Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Schedule of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block] Interest rate swap derivative assets Derivative Asset Total revenues Business Acquisition, Pro Forma Revenue Other Deferred Tax Liabilities, Other AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax 2016 Restructuring Program 2016 Restructuring Program [Member] 2016 Restructuring Program Number of shares under stock awards, vested and expected to vest at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Other current liabilities Other Current Liabilities [Member] Uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Issuance of restricted stock and stock options exercised, net Restricted Stock, Value, Shares Issued Net of Tax Withholdings Line of Credit Facility [Table] Line of Credit Facility [Table] Non-U.S. state tax authority Non-U.S. state tax authority [Member] Non-U.S. state tax authority [Member] Amortization of actuarial loss included in SG&A Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Participant contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Goodwill, gross, beginning balance Goodwill, gross, ending balance Goodwill, Gross Lipitor ® Lipitor ® [Member] Lipitor ® Long-term debt Long-term Debt, Excluding Current Maturities Schedule of Goodwill [Table] Schedule of Goodwill [Table] Upjohn Euro Notes Upjohn Euro Notes [Member] Upjohn Euro Notes Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Divestiture Of Business, Percentage Ownership In Combined Company After Transaction Divestiture Of Business, Percentage Ownership In Combined Company After Transaction Divestiture Of Business, Percentage Ownership In Combined Company After Transaction Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Average remaining contractual term for options exercisable, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Plan settlements Defined Benefit Plan, Plan Assets, Payment for Settlement Development Milestone Payments Development Milestone Payments Development Milestone Payments Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Amortization of Inventory Step Up Amortization of Inventory Step Up Amortization of Inventory Step Up Other Foreign Operations Other [Member] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Net (loss) earnings Net loss Net earnings Net (loss) earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Amount of operating leases not yet commenced Lessee, Operating Lease, Lease Not yet Commenced, Amount Lessee, Operating Lease, Lease Not yet Commenced, Amount Brands Brands [Member] Brands Inventory reserves Inventory Valuation Reserves Vest after three years Vest in three years or less [Member] Vest in three years or less Construction in progress Construction in Progress [Member] Cash, cash equivalents and restricted cash — beginning of period Cash, cash equivalents and restricted cash — end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Common Stock, Par or Stated Value Per Share Ordinary shares, par value, in USD per share Common Stock, Par or Stated Value Per Share Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Operating lease assets Deferred Tax Assets, Operating Lease, Right-of-Use Assets Deferred Tax Assets, Operating Lease, Right-of-Use Assets Measurement Input, EBITDA Multiple [Member] Measurement Input, EBITDA Multiple [Member] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Current assets: Assets, Current [Abstract] Other items, net Proceeds from (Payments for) Other Financing Activities Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Number Of Products Number Of Products Number Of Products Components of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Impairment of Long-Lived Assets Policy Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Internal Revenue Service (IRS) Internal Revenue Service (IRS) [Member] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Number of shares exercised Number of shares under stock awards, exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Contingent consideration payments Payments Business Combination Contingent Consideration Liability Payments Business Combination Contingent Consideration Liability Payments Other comprehensive (loss) earnings, net of tax Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Estimated Litigation Liability Estimated Litigation Liability Amended Anticompetitive Conduct with Generic Drugs Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Maximum Leverage Ratio, Period Two Maximum Leverage Ratio, Period Two Maximum Leverage Ratio, Period Two Accrued interest Interest Payable, Current Gain (Loss) on Fair Value Hedges Recognized in Earnings Gain (Loss) on Fair Value Hedges Recognized in Earnings Payments for Business Separation Payments for Business Separation Payments for Business Separation Reductions due to expirations of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Other current assets Other Current Assets [Text Block] Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Auditor Firm ID Auditor Firm ID Product Liability Product Liability [Member] Product Liability Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Projected benefit obligation, beginning of year Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Buildings and improvements Building and Building Improvements [Member] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Issuance of restricted stock and stock options exercised, net (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Notional amount of derivative Derivative Asset, Notional Amount Europe Segment Europe Segment [Member] Europe Segment Weighted average grant-date fair value per share, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Effexor ® Effexor ® [Member] Effexor ® Class of Stock [Domain] Class of Stock [Domain] Cash paid to acquire asset Payments to Acquire Businesses, Gross Norvasc ® Norvasc ® [Member] Norvasc ® Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Ownership [Domain] Ownership [Domain] Checks/ Credits Issued to Third Parties Accounts Receivable, Credits Issued to Third Parties Accounts Receivable, Credits Issued to Third Parties Gross sales Revenue from Contract with Customer, Gross Revenue from Contract with Customer, Gross Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other current assets Other Assets, Current Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Equity Method Investments, Reduction In Long-Term Obligations Equity Method Investments, Reduction In Long-Term Obligations Equity Method Investments, Reduction In Long-Term Obligations Litigation reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies Asset-backed Securities [Member] Asset-backed Securities [Member] Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Liability derivatives, fair value Derivative Liability, Fair Value, Gross Liability Forfeiture rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate Share-based compensation arrangement by Share-based payment award, fair value assumptions, Forfeiture rate Income Tax Examination, Reserve for Uncertain Tax Position Income Tax Examination, Reserve for Uncertain Tax Position Income Tax Examination, Reserve for Uncertain Tax Position SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Beginning balance Ending balance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Payments for Rent Payments for Rent Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class Income taxes payable Accrued Income Taxes, Current 2016 Senior Revolving Credit Facility 2016 Senior Revolving Credit Facility [Member] 2016 Senior Revolving Credit Facility [Member] Inventories Policy Inventory, Policy [Policy Text Block] Non-U.S. Current Current Foreign Tax Expense (Benefit) Nature of Operations Nature of Operations [Text Block] Pension Benefits Pension Plan [Member] Intellectual Property Developed Technology Rights [Member] Mature within one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Goodwill Impairment Test, Measurement Input, Reduction Goodwill Impairment Test, Measurement Input, Reduction Goodwill Impairment Test, Measurement Input, Reduction Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Transaction related and other special items Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Momenta Momenta [Member] Momenta [Member] 2048 Senior Notes [Member] 2048 Senior Notes [Member] 2048 Senior Notes [Member]